translational medicine

Antigenix Therapeutics Inc, a Syridex Bio Company, is a biotechnology company developing antibody-based therapies, including antibody-drug conjugate (ADC) therapies, for cancers resistant to current treatments. Its patented antibody technology targets a cancer-specific marker to attack tumors while sparing healthy cells. The company develops monoclonal antibody-based therapies targeting novel, tumor-specific cell surface proteins and is preparing a pre-clinical program toward IND submission.

Read more

antibody-drug conjugate developmentbiotech venture creationclinical advancementpre-clinical program development

Aspera Biomedicines is a space-accelerated biotechnology company founded in 2021 by Dr. Catriona Jamieson, MD, PhD, building on two decades of cancer stem cell research at Stanford and UC San Diego. It develops first-in-class therapies targeting cancer stem cells to end cancer relapse and extend human healthspan, partnering with NASA to study cancer evolution in low-Earth orbit microgravity.

Read more

cancer stem cell researchlow-Earth orbit researchnanobioreactor platformsprotein crystallization in microgravityspace-accelerated drug discovery